101 related articles for article (PubMed ID: 11933396)
1. NESP researchers present latest data at ASN.
Nephrol News Issues; 2000 Nov; 14(12):56, 58. PubMed ID: 11933396
[No Abstract] [Full Text] [Related]
2. Rebates for anti-anemia drugs draw response from FDA, CMS.
Sipkoff M
Manag Care; 2007 Jun; 16(6):17-8. PubMed ID: 17682732
[No Abstract] [Full Text] [Related]
3. [Advances in therapy of renal anemia: darbepoetin alfa].
Schaefer R
Wien Klin Wochenschr; 2002 Dec; 114(23-24):955-7. PubMed ID: 12635460
[No Abstract] [Full Text] [Related]
4. Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease.
Nissenson AR
Am J Kidney Dis; 2001 Dec; 38(6):1390-7. PubMed ID: 11728981
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease anemia management: what should be done?
Szczech LA
Blood Purif; 2011; 31(1-3):186-8. PubMed ID: 21228588
[TBL] [Abstract][Full Text] [Related]
6. Managing anemia. What do we do now? Views from Canada.
Mendelssohn DC; Muirhead N; Manns BJ
Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
[No Abstract] [Full Text] [Related]
7. Long-acting erythropoietin: clinical studies and potential uses in neonates.
Ohls RK; Dai A
Clin Perinatol; 2004 Mar; 31(1):77-89. PubMed ID: 15183658
[TBL] [Abstract][Full Text] [Related]
8. An ongoing study of anemia correction in chronic kidney disease.
Pfeffer MA;
N Engl J Med; 2007 Mar; 356(9):959-61. PubMed ID: 17329707
[No Abstract] [Full Text] [Related]
9. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
10. Finding a rational approach to ESA therapy--for payers and patients.
Messana A
Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
[No Abstract] [Full Text] [Related]
11. [Anemia and renal failure: efficacy of its control].
Fort J
Nefrologia; 2006; 26 Suppl 3():28-32. PubMed ID: 17469424
[No Abstract] [Full Text] [Related]
12. Does TREAT give the boot to ESAs in the treatment of CKD anemia?
Singh AK
J Am Soc Nephrol; 2010 Jan; 21(1):2-6. PubMed ID: 20035034
[No Abstract] [Full Text] [Related]
13. Darbepoetin alfa.
Vance R
Clin J Oncol Nurs; 2003; 7(5):599-600. PubMed ID: 14603561
[No Abstract] [Full Text] [Related]
14. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
Adamson JW; Eschbach JW
Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
[No Abstract] [Full Text] [Related]
15. [Biological similarity of erythropoietin: controlled maturation].
Combe C
Nephrol Ther; 2009 Feb; 5 Spec No1():1-2. PubMed ID: 19233074
[No Abstract] [Full Text] [Related]
16. Catch a falling star: wonder drug EPO may be down, but not out.
Neumann ME
Nephrol News Issues; 2010 Sep; 24(10):8. PubMed ID: 20942325
[No Abstract] [Full Text] [Related]
17. Rate of progression of chronic renal failure in predialysis patients treated with erythropoietin.
Abels R
Semin Nephrol; 1990 Mar; 10(2 Suppl 1):20-5. PubMed ID: 2192413
[No Abstract] [Full Text] [Related]
18. EPO--one year later. Fighting anemia in the courtroom.
Riley JB; Pristave RJ
Nephrol News Issues; 1990 May; 4(5):27. PubMed ID: 2348877
[No Abstract] [Full Text] [Related]
19. Erythropoietin for anemia.
Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
[No Abstract] [Full Text] [Related]
20. [Erythropoietin in the treatment of anemia in chronic renal insufficiency].
Valderrábano F
An Med Interna; 1991 Jun; 8 Suppl 2():22-3. PubMed ID: 1878467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
